- Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury
Zaynab Shakkour et al, 2021, Current Medicinal Chemistry CrossRef - Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Yao Xiang et al, 2024, Archives of Toxicology CrossRef - Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
Teresa Cunha-Oliveira et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef - Edaravone Plays Protective Effects on LPS-Induced Microglia by Switching M1/M2 Phenotypes and Regulating NLRP3 Inflammasome Activation
Jiping Li et al, 2021, Frontiers in Pharmacology CrossRef - Sorafenib and edaravone protect against renal fibrosis induced by unilateral ureteral obstruction via inhibition of oxidative stress, inflammation, and RIPK-3/MLKL pathway
Mohamed A. Abou Taha et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef - A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
Sarmistha Saha et al, 2022, Frontiers in Cellular Neuroscience CrossRef - Edaravone Alleviates Traumatic Brain Injury by Inhibition of Ferroptosis via FSP1 Pathway
Haoyu Shi et al, 2024, Molecular Neurobiology CrossRef - Repurposing of Various Current Medicines as Radioprotective Agents
Rajwinder Kaur et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef - Enhancing the Neuroprotection Potential of Edaravone in Transient Global Ischemia Treatment with Glutathione- (GSH-) Conjugated Poly(methacrylic acid) Nanogel as a Promising Carrier for Targeted Brain Drug Delivery
Faezeh Mozafari et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef - Edaravone in the treatment of concussion and post-concussion syndrome
O.A. Halushko, 2023, Infusion & Chemotherapy CrossRef - An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study
Shotaro Haji et al, 2023, JMIR Research Protocols CrossRef - Edaravone Attenuates Disease Severity of Experimental Auto-Immune Encephalomyelitis and Increases Gene Expression of Nrf2 and HO-1
D MICHALIČKOVÁ et al, 2022, Physiological Research CrossRef - Edaravone mitigates hemorrhagic cystitis by modulating Nrf2, TLR‐4/NF‐κB, and JAK1/STAT3 signaling in cyclophosphamide‐intoxicated rats
Emad H. M. Hassanein et al, 2021, Journal of Biochemical and Molecular Toxicology CrossRef - Nrf2 Ablation Promotes Alzheimer’s Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress
Peng Ren et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef - NIR-II Dyad-Doped Ratiometric Nanosensor with Enhanced Spectral Fidelity in Biological Media for In Vivo Biosensing
Peng Yu et al, 2022, Nano Letters CrossRef - Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury
Zaynab Shakkour et al, 2021, The Neuroscientist CrossRef - Auricular Electroacupuncture for Late Posttraumatic Epilepsy after Severe Brain Injury: A Retrospective Study
Cui-Cui Shen et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef - Edaravone Dexborneol Alleviates Cerebral Ischemic Injury via MKP-1-Mediated Inhibition of MAPKs and Activation of Nrf2
Wen Zhang et al, 2022, BioMed Research International CrossRef - Docetaxel-induced cognitive impairment in rats can be ameliorated by edaravone dexborneol: Evidence from the indicators of biological behavior and anisotropic fraction
Ping Liu et al, 2023, Frontiers in Neuroscience CrossRef